Breaking News on Global Pharmaceutical Technology & Manufacturing

Ingredients: Top Headlines


US investor buys J&J's opiate API business and announces restructuring


21-Jul-2016 - SK Capital has rejigged the senior teams at opiate API maker Noramco and raw material supplier Tasmanian Alkaloids just weeks after buying the firms from Johnson & Johnson (J&J).

Related news

News in brief

Patheon will list on NYSE today

21-Jul-2016 - API and drug maker Patheon will begin trading on the New York Stock Exchange under the symbol PTHN later today.

Lonza: Biologic APIs boosted H1 revs and CAR-T deal will help sustain growth in H2

20-Jul-2016 - Lonza has increased its 2016 earnings guidance after strong H1 growth of its biologic APIs business.

Johnson Matthey: Q1 API revenues down on order timings

20-Jul-2016 - Johnson Matthey said a slight decrease in API sales during the first quarter of its fiscal year was due to the timing of customer orders.

FDA adds 4 API manufacturers to 'Red List'

19-Jul-2016 - Two Chinese and two Indian companies have been banned from importing APIs to the US – one manufacturer says it’s making GMP compliance a “priority.”

China's complex API regs fuelling US meth problem says congressional committee

19-Jul-2016 - Legal loopholes and poor enforcement let criminals in China divert APIs for illegal drug production according to a US congressional committee which says the country is fast becoming the major global supplier of crystal meth precursors.


MilliporeSigma has signed an excipient distribution deal with PCAS

18-Jul-2016 - MilliporeSigma will distribute range of lactic acid sustained release excipients under a deal with French developer PCAS.

Cambrex makes 'Pharma 3' plant operational after equipment delivery delays

13-Jul-2016 - Cambrex has brought a delayed Iowa API facility online and completed work on a shell plant that can be tailored to specific projects. 

Ingredients: Featured news

Key Industry Events


Access all events listing

Our events, Shows & Conferences...